Bixiye
QP83-24 MHCP Pharmacy Benefit Exclusion for Tremfya®, Tecentriq Hybreza™ and Ocrevus Zunovo™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Natiijooyinka Raadinta
Soo bandhiga 591 - 600 ee natiijooyinka 4144
Bixiye
QP82-24 Enhanced Authorization Submissions through Availity Essentials
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP80-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Dukaamaysiga & Barashada
2025 Spanish Individual & Family Dental and Vision Decision Guide
Dukaamaysiga & Barashada
2025 Spanish Individual & Family Decision Guide
Dukaamaysiga & Barashada
2025 Spanish Medicare Decision Guide
Guía de Decisiones de Medicare.
Bixiye
2024 November Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
P72-24 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
P70-24 Continuous Glucose Monitor Billing for Medicare Products
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024